Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Benderly

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
European Journal of Neurology|June 23, 2009
Increased insulin resistance and risk of incident cerebrovascular events in patients with pre-existing atherothrombotic diseaseD Tanne, A Tenenbaum, V Boyko, et al.
Journal of Cardiovascular Electrophysiology|March 10, 2000
Are routine arrhythmia inductions necessary in patients with pectoral implantable cardioverter defibrillators?M Glikson, D Luria, P A Friedman, et al.
Journal of Cardiovascular Risk|June 1, 1995
Asymptomatic hyperglycemia in coronary heart disease: frequency and associated lipid and lipoprotein levels in the bezafibrate infarction prevention (BIP) register. The BIP Study GroupS Behar, V Boyko, M Benderly, et al.
The American Journal of Medicine|November 3, 2001
A prospective study of plasma fibrinogen levels and the risk of stroke among participants in the bezafibrate infarction prevention studyD Tanne, M Benderly, U Goldbourt, et al.
Journal of Clinical Epidemiology|June 1, 1995
Plasma fibrinogen levels and their correlates in 6457 coronary heart disease patients. The Bezafibrate Infarction Prevention (BIP) StudyE Barasch, M Benderly, E Graff, et al.
Prostate Cancer and Prostatic Diseases|February 13, 2013
Association between metabolic syndrome, diabetes mellitus and prostate cancer riskY R Lawrence, O Morag, M Benderly, et al.
Clinical Cardiology|July 20, 2001
Oral antidiabetic treatment in patients with coronary disease: time-related increased mortality on combined glyburide/metformin therapy over a 7.7-year follow-upE Z Fisman, A Tenenbaum, V Boyko, et al.
Statistics in Medicine|February 18, 2009
Systematically missing confounders in individual participant data meta-analysis of observational cohort studies, Dan Jackson, Ian White, et al.
JAMA|October 13, 2005
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis, John Danesh, Sarah Lewington, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
European Journal of Neurology|June 23, 2009
Increased insulin resistance and risk of incident cerebrovascular events in patients with pre-existing atherothrombotic diseaseD Tanne, A Tenenbaum, V Boyko, et al.
Journal of Cardiovascular Electrophysiology|March 10, 2000
Are routine arrhythmia inductions necessary in patients with pectoral implantable cardioverter defibrillators?M Glikson, D Luria, P A Friedman, et al.
Journal of Cardiovascular Risk|June 1, 1995
Asymptomatic hyperglycemia in coronary heart disease: frequency and associated lipid and lipoprotein levels in the bezafibrate infarction prevention (BIP) register. The BIP Study GroupS Behar, V Boyko, M Benderly, et al.
The American Journal of Medicine|November 3, 2001
A prospective study of plasma fibrinogen levels and the risk of stroke among participants in the bezafibrate infarction prevention studyD Tanne, M Benderly, U Goldbourt, et al.
Journal of Clinical Epidemiology|June 1, 1995
Plasma fibrinogen levels and their correlates in 6457 coronary heart disease patients. The Bezafibrate Infarction Prevention (BIP) StudyE Barasch, M Benderly, E Graff, et al.
Prostate Cancer and Prostatic Diseases|February 13, 2013
Association between metabolic syndrome, diabetes mellitus and prostate cancer riskY R Lawrence, O Morag, M Benderly, et al.
Clinical Cardiology|July 20, 2001
Oral antidiabetic treatment in patients with coronary disease: time-related increased mortality on combined glyburide/metformin therapy over a 7.7-year follow-upE Z Fisman, A Tenenbaum, V Boyko, et al.
Statistics in Medicine|February 18, 2009
Systematically missing confounders in individual participant data meta-analysis of observational cohort studies, Dan Jackson, Ian White, et al.
JAMA|October 13, 2005
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis, John Danesh, Sarah Lewington, et al.
Pageof 2